Showing 1 - 3 results of 3 for search 'Teresa L Burgess', query time: 0.02s Refine Results
  1. 1
    A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology.

    A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology. by Teresa L Burgess, Joshua D Amason, Jeffrey S Rubin, Damien Y Duveau, Laurence Lamy, David D Roberts, Catherine L Farrell, James Inglese, Craig J Thomas, Thomas W Miller

    Published 2020-01-01
    Get full text
    Article
  2. 2
    Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling

    Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling by Fabiola Cecchi, Karen Rex, Joanna Schmidt, Cathy D. Vocke, Young H. Lee, Sandra Burkett, Daniel Baker, Michael A. Damore, Angela Coxon, Teresa L. Burgess, Donald P. Bottaro

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.

    Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors. by Thomas W Miller, Joshua D Amason, Elsa D Garcin, Laurence Lamy, Patricia K Dranchak, Ryan Macarthur, John Braisted, Jeffrey S Rubin, Teresa L Burgess, Catherine L Farrell, David D Roberts, James Inglese

    Published 2019-01-01
    Get full text
    Article

Search Tools: